# Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)

> **NCT05814640** · PHASE1,PHASE2 · RECRUITING · sponsor: **First Affiliated Hospital of Chongqing Medical University** · enrollment: 520 (estimated)

## Conditions studied

- Depression
- Sequestra

## Interventions

- **DRUG:** Fluoxetine
- **DRUG:** Sertraline
- **DRUG:** Vortioxetine
- **DRUG:** Duloxetine
- **DRUG:** Aripiprazole
- **DRUG:** Lithium Carbonate
- **DRUG:** Olanzapine
- **BEHAVIORAL:** GCBT

## Key facts

- **NCT ID:** NCT05814640
- **Lead sponsor:** First Affiliated Hospital of Chongqing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-20
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-07-01
- **Target enrollment:** 520 (ESTIMATED)
- **Last updated:** 2026-01-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05814640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05814640, "Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05814640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*